Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 16.04B | 15.63B | 17.37B | 15.54B | 12.46B |
Gross Profit | 4.50B | 4.63B | 4.98B | 4.60B | 3.81B |
EBITDA | 2.11B | 2.32B | 2.96B | 2.73B | 1.79B |
Net Income | 591.47M | 1.04B | 1.33B | 1.26B | 727.41M |
Balance Sheet | |||||
Total Assets | 20.64B | 21.12B | 20.84B | 21.38B | 17.12B |
Cash, Cash Equivalents and Short-Term Investments | 1.63B | 2.74B | 2.98B | 3.22B | 1.50B |
Total Debt | 5.06B | 5.34B | 6.39B | 7.30B | 7.87B |
Total Liabilities | 8.12B | 9.04B | 9.81B | 11.61B | 11.49B |
Stockholders Equity | 12.33B | 12.04B | 11.00B | 9.77B | 5.63B |
Cash Flow | |||||
Free Cash Flow | -752.22M | 818.20M | 668.43M | -636.94M | 195.04M |
Operating Cash Flow | 1.67B | 2.04B | 2.62B | 1.27B | 1.77B |
Investing Cash Flow | -2.34B | -1.07B | -1.88B | -1.84B | -1.33B |
Financing Cash Flow | -450.68M | -1.20B | -983.56M | 2.29B | -164.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥4.80B | 7.14 | 1.75% | 3.62% | 48.23% | ||
72 Outperform | ¥6.90B | 20.73 | 1.02% | 8.72% | -17.33% | ||
71 Outperform | ¥18.98B | 14.32 | 1.24% | -5.25% | -11.55% | ||
71 Outperform | ¥9.04B | 16.41 | 3.53% | 8.60% | 55.62% | ||
66 Neutral | ¥15.53B | 26.86 | 2.92% | -2.57% | -51.75% | ||
65 Neutral | $10.81B | 15.25 | 5.26% | 1.93% | 3.11% | -26.99% | |
64 Neutral | ¥6.09B | 10.29 | 3.05% | 2.61% | -43.23% |